Previous reports confirmed its proapoptotic activity occurs with the activation of caspase 3 and the cleavage of PARP in preclinical models of leukemia, glioblastoma, or cervical cancer [15,16,17,36], which is similar to our observations. Here, CASP3 is linked to cervical carcinoma.